Name | UNC9995 |
---|
Description | UNC9995 is a β-arrestin2-biased agonist of dopamine receptor Drd2. UNC9995 inhibits NLRP3 inflammasome activation by enhancing β-arrestin2-NLRP3 interaction, thus prevents neuronal degeneration. Futhermore, UNC9995 activates the Drd2/β-arrestin2 signaling to prevent inflammation-related genes transcription-induced by JAK/STAT3. UNC9995 improves depressive behavior in mouse model, and improves astrocytes dysfunctions[1]. |
---|---|
Related Catalog | |
Target |
D2 Receptor |
In Vitro | UNC9995(10 μM;1 小时)预处理原代星形胶质细胞,使它受IL-6(300 ng/mL;24 小时)诱导后,STAT3 和 β-arrestin2 的结合得到增强。它还抑制 STING、TBK1、JAK 的激活[1]。 UNC9995(1、5、10 和 20 μM;1 小时)能够消除细胞凋亡和炎症,当用 IL-6 (300 ng/mL;24 小时) 刺激 WT 和 Arrb2−/− 星形胶质细胞后[1]。 Western Blot Analysis[1] Cell Line: Primary astrocytes Concentration: 10 μM Incubation Time: 1 h for pre-incubation; with 300 ng/mL IL-6 Result: Enhanced the interaction between STAT3 and β-arrestin2. Abolished the activation of cGAS-STING and JAK/STAT3 pathway stimulated by IL-6, decreased the level of p-STING, p-TBK1, p-JAK. |
In Vivo | UNC9995(2 mg/kg/天,腹腔注射,2 周)在小鼠的慢性社交失败应激 (CSDS) 模型和慢性不可预知轻度应激 (CUMS) 模型中,改善了抑郁样行为表型并改善海马体中星形胶质细胞的丢失[1]。 Animal Model: Chronic unpredictable mild stress (CUMS) mouse model[1] Dosage: 2 mg/kg/d Administration: IP; 2 weeks Result: Improved depressive-like symptoms of CUMS mouse model in WT mice but not Arrb2−/− mice. |
References |
Molecular Formula | C20H21Cl2N3OS |
---|---|
Molecular Weight | 422.37 |